Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome

Women with polycystic ovary syndrome (PCOS) have an adverse metabolic profile with an increased risk of prediabetes and type 2 diabetes (T2DM); however, it is unclear if PCOS is associated with increased cardiovascular events in later years independent of the presence of T2DM. Many therapies have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Alalami, Huda, Sathyapalan, Thozhukat, Atkin, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378434/
https://www.ncbi.nlm.nih.gov/pubmed/30800265
http://dx.doi.org/10.1177/2042018818805674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378434/
https://www.ncbi.nlm.nih.gov/pubmed/30800265
http://dx.doi.org/10.1177/2042018818805674

Ejemplares similares